These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 34488809)
1. Comprehensive analysis of LASS6 expression and prognostic value in ovarian cancer. Xing J; Yi J J Ovarian Res; 2021 Sep; 14(1):117. PubMed ID: 34488809 [TBL] [Abstract][Full Text] [Related]
2. Increased Expression of Zou R; Xu H; Li F; Wang S; Zhu L DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631 [TBL] [Abstract][Full Text] [Related]
3. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Mizutani Y; Kihara A; Igarashi Y Biochem J; 2005 Aug; 390(Pt 1):263-71. PubMed ID: 15823095 [TBL] [Abstract][Full Text] [Related]
4. Expression profiles and prognostic values of BolA family members in ovarian cancer. Zhu M; Xiao S J Ovarian Res; 2021 Jun; 14(1):75. PubMed ID: 34078439 [TBL] [Abstract][Full Text] [Related]
5. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins. Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227 [TBL] [Abstract][Full Text] [Related]
6. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments. Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343 [TBL] [Abstract][Full Text] [Related]
7. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis. Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782 [TBL] [Abstract][Full Text] [Related]
8. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis. Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer. Zhang P; Su T; Zhang S J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143 [TBL] [Abstract][Full Text] [Related]
10. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics]. Li X; He J; Yu M; Zhang W; Sun J Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212 [TBL] [Abstract][Full Text] [Related]
11. Prognostic values of S100 family mRNA expression in ovarian cancer. Ma N; Zhu L; Yang L; Cui Y; Zhan Y Cancer Biomark; 2019; 25(1):67-78. PubMed ID: 31033462 [TBL] [Abstract][Full Text] [Related]
12. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay. Zhang L; Sun L; Zhang B; Chen L Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312 [TBL] [Abstract][Full Text] [Related]
13. Identification of metastasis and prognosis-associated genes for serous ovarian cancer. Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146 [TBL] [Abstract][Full Text] [Related]
14. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis. Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978 [TBL] [Abstract][Full Text] [Related]
15. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments. Zhu H; Wang G; Zhu H; Xu A J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638 [No Abstract] [Full Text] [Related]
16. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis. Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma. Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238 [TBL] [Abstract][Full Text] [Related]
18. ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining. Chen Y; Tian D; Chen X; Tang Z; Li K; Huang Z; Fu Y; Feng Y; Yang Z Int J Gen Med; 2021; 14():967-981. PubMed ID: 33790626 [TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification. Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer. Wu B; Xi S BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]